EVEROLIMUS

38731 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking EVEROLIMUS:

# Side effect Count
0 DEATH 5300
1 MALIGNANT NEOPLASM PROGRESSION 3688
2 DIARRHOEA 3210
3 FATIGUE 3088
4 STOMATITIS 2774
5 DYSPNOEA 2240
6 NAUSEA 2208
7 PYREXIA 1842
8 DECREASED APPETITE 1735
9 RASH 1695
See all common reactions for EVEROLIMUS

EVEROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 71 0.4671
1 INFUSION SITE COLDNESS 23 0.3710
2 ANGIOFIBROMA 25 0.3676
3 PIK3CA-ACTIVATED MUTATION 47 0.3672
4 POLYOMAVIRUS VIRAEMIA 78 0.2776
5 PANCREATIC NEUROENDOCRINE TUMOUR 88 0.2316
6 NEUROENDOCRINE TUMOUR 182 0.2043
7 ASTROCYTOMA, LOW GRADE 20 0.1869
8 BLOOD CHROMOGRANIN A INCREASED 54 0.1667
9 GAMMA-GLUTAMYLTRANSFERASE DECREASED 24 0.1569
See all enriched reactions for EVEROLIMUS